John Mastrototaro, PhD

John Mastrototaro, PhD, has over 30 years of experience in the medical device industry, leading innovation and bringing new products to the market. Before becoming CEO of Movano, he was the COO of Orthosensor, Inc., which was acquired by Stryker (NYSE:SYK). Previously, Mastrototaro spent the majority of his career with Medtronic and MiniMed, where he was instrumental in initiating and leading a series of firsts in the world of diabetes, including the ambulatory continuous glucose monitoring system, the sensor augmented insulin pump and the early generations of the artificial pancreas. During his tenure in Medtronic’s Diabetes division, Mastrototaro held a number of positions, including CTO, VP of R&D and Business Development and Global VP of Clinical Research and Health Affairs. He was also Medtronic’s first VP of Informatics, where he helped develop a corporate strategy for the use of data and analytics to improve healthcare delivery.